BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 32650852)

  • 1. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
    Bartoš V
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
    Bartoš V; Kullová M
    Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
    Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
    Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
    Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
    Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of angiogenesis with other immunohistochemical markers in cutaneous basal and squamous cell carcinomas.
    Ciortea CD; Jung I; Gurzu S; Kövecsi A; Turdean SG; Bara T
    Rom J Morphol Embryol; 2015; 56(2 Suppl):665-70. PubMed ID: 26429157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
    Kiely JR; Patel AJK
    J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
    Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
    Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck.
    Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
    Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
    J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
    Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
    J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
    Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
    J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sun-Exposed versus Sun-Protected Cutaneous Basal Cell Carcinoma: Clinico-Pathological Profile and p16 Immunostaining.
    Hasan A; Kandil AM; Al-Ghamdi HS; Alghamdi MA; Nasr M; Naeem SA; Abd-Elhay WM; Mohamed OKE; Ibrahim HSA; Ahmed EM; Abdrabo AEM; Elgohary SA
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.